MarketBeat
10 Nov 2026, 06:13 UTC · 1d ago
WELL Health Technologies Q3 Earnings Call Highlights
Impact · against what's priced in
WELL Health is facing a negative catalyst as revenue guidance shifts to the low end of previous ranges, confirming a deceleration trend the market is already cautious about. While Canadian Clinics growth is strong, the net loss from impairments and a decline in operating adjusted free cash flow offset these gains.
- WELL−0.20
Already priced in
- The price assumes
A deceleration from the recent 35.8% revenue growth to the 21.5% annual rate
The company guiding 2026 revenue to the low end of its range (approx. CAD 1.58 billion) reinforces the market's existing bearish lean toward growth deceleration.
What WELL's price assumes · Sep 10
